DI RESTA, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 507
NA - Nord America 446
AS - Asia 233
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 3
Totale 1.197
Nazione #
US - Stati Uniti d'America 446
SE - Svezia 222
IT - Italia 129
CN - Cina 116
SG - Singapore 101
RU - Federazione Russa 61
FI - Finlandia 38
DE - Germania 24
IE - Irlanda 10
GR - Grecia 7
IN - India 6
IR - Iran 6
GB - Regno Unito 5
CL - Cile 3
CM - Camerun 3
A1 - Anonimo 2
BE - Belgio 2
EU - Europa 2
NL - Olanda 2
PH - Filippine 2
SM - San Marino 2
AT - Austria 1
FR - Francia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
TR - Turchia 1
Totale 1.197
Città #
Ashburn 95
Singapore 63
Lawrence 57
Princeton 57
New York 52
Shanghai 44
Helsinki 32
Milan 32
Moscow 31
Boardman 24
Rome 16
Seattle 14
Dublin 10
Guangzhou 6
Lappeenranta 6
Dallas 5
Viareggio 5
Ardabil 4
Athens 4
Atlanta 4
Beijing 4
Los Angeles 4
Shenzhen 4
Turin 4
Washington 4
Jiaxing 3
Lykovrysi 3
Manchester 3
Pune 3
Santiago 3
Wuxi 3
Amsterdam 2
Antwerp 2
Aosta 2
Bitonto 2
Bologna 2
Brescia 2
Cebu City 2
Chandler 2
Falkenstein 2
Indore 2
Las Vegas 2
Malandriano 2
Modena 2
Nanjing 2
Naples 2
Nerviano 2
Orta Nova 2
Piombino 2
Pistoia 2
Portici 2
San Marino 2
Sant'Ambrogio di Valpolicella 2
Santa Clara 2
Seriate 2
Tübingen 2
Vaprio d'Adda 2
Varedo 2
Xi'an 2
Xuzhou 2
Bergamo 1
Borås 1
Budapest 1
Campodolcino 1
Cantù 1
Catania 1
Chennai 1
Chicago 1
Clifton 1
Cremona 1
Dalian 1
Foshan 1
Girasole 1
Görwihl 1
Harbin 1
Izmir 1
Jieyang 1
Jingmen 1
Jinhua 1
Kish 1
Kunming 1
Lima region 1
Macerata 1
Mairano 1
Monza 1
Munich 1
Newark 1
Oslo 1
Palermo 1
Piacenza 1
Portland 1
Riga 1
Rockville 1
Taizhou 1
Temple Hills 1
Vientiane 1
Xiamen 1
Zanjan 1
Zhengzhou 1
Zweibrücken 1
Totale 697
Nome #
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 35
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 34
Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests 34
Machine Learning based on laboratory medicine test results in diagnosis and prognosis for COVID-19 patients: A systematic review 33
Concealed Substrates in Brugada Syndrome: Isolated Channelopathy or Associated Cardiomyopathy? 30
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 30
Cardiac and Neuromuscular Features of Patients with LMNA-Related Cardiomyopathy 29
Electrophysiological properties of mutant alpha2beta4 nAChR linked to a form of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) 27
Erratum: Genetic testing in neurology exploiting next generation sequencing: State of art (Neural Regeneration Research (2020) 15:2 (265-266) DOI: 10.4103/1673-5374.265554) 27
Cardiac magneti resonance and arrhythmic risk stratification of cardiomyopathy associated with lamin A/C mutations: results from a 5 years study 27
A Brugada Syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 25
Analytical Ancestry: Evolution of the Array in Analysis 25
Current Updates on Expanded Carrier Screening: New Insights in the Omics Era 24
Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench 24
Challenges of the Effectiveness of Traumatic Brain Injuries Biomarkers in the Sports-Related Context 22
Effect of Carbamazepine and Related Compounds on Ligand-Gated Channels: Possible Implications for Synaptic Transmission and Side Effects. 22
Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy 22
Impaired turnover of hyperfused mitochondria in severe axonal neuropathy due to a novel DRP1 mutation 22
Brugada syndrome genetics is associated with phenotype severity 22
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects 22
Molecular diagnostics in the prenatal age: technological evolution and ethical implications in reproductive medicine|La diagnostica molecolare in epoca prenatale: evoluzione tecnologica ed implicazioni etiche in medicina della riproduzione 22
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 21
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy 20
Functional Characterisation of the Rare SCN5A p.E1225K Variant, Segregating in a Brugada Syndrome Familial Case, in Human Cardiomyocytes from Pluripotent Stem Cells 20
A novel homozygous mutation in the TRDN gene causes a severe form of pediatric malignant ventricular arrhythmia 20
Current scenario of the genetic testing for rare neurological disorders exploiting next generation sequencing 20
Genetic background of mitral valve prolapse 20
Exploratory assessment of serological tests to determine antibody titer against SARS-CoV-2: Appropriateness and limits 19
Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine 18
Electrocardiogram Changes in the Postictal Phase of Epileptic Seizure: Results from a Prospective Study 18
Alpha2-I279N human nicotinic acetylcholine receptors, linked to a form of nocturnal epilepsy, present higher sensitivity to agonists 18
Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign 18
Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2 17
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 17
SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome 17
The gender impact assessment among healthcare workers in the sars-cov-2 vaccination—an analysis of serological response and side effects 17
High-throughput genetic characterization of a cohort of Brugada syndrome patients. 16
Premature cardiac senescence in patients with lamin A/C mutations: at least 5 years gap from electrical to mechanical dysfunction 16
Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: A pilot study 16
Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy 16
Advance in Genomics of Rare Genetic Diseases 15
The total testing process harmonization: the case study of SARS-CoV-2 serological tests 14
Genetic factors predisposing to bronchopulmonary dysplasia. A pilot study by exome sequencing and pathways analysis 14
P3170Innovative approach for risk stratification of LMNA-related cardiomyopathy: results from an integrated cardiological and neurological 10-year follow-up multicentre study 14
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 14
Evaluation of three advanced methodologies, COLD-PCR, microarray and ddPCR, for identifying the mutational status by liquid biopsies in metastatic colorectal cancer patients 14
Evidence of significant difference in key covid-19 biomarkers during the italian lockdown strategy. A retrospective study on patients admitted to a hospital emergency department in northern italy 14
Increased sensitivity of the neuronal nicotinic receptor alpha2 subunit causes familial epilepsy with nocturnal wandering and ictal fear 13
Evaluation of damaging effects of splicing mutations: validation of an in vitro method for diagnostic laboratories 13
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 13
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 13
Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear 13
Editorial: Whole Genome Sequencing for rare diseases 12
Implementation of companion diagnostics in the clinical laboratories: the BRAF example in Melanoma 12
Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis 12
Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities 12
Generation of a triadin KnockOut syndrome zebrafish model 12
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 11
Melanocortin-1 receptor (MC1R): a review for dermatologists 11
Genetics can contribute to the prognosis of the Brugada syndrome: a pilot model for risk stratification. 11
Increased sensitivity of the alpha-2 neuronal nicotinic receptor causes familial epilepsy with nocturnal wandering and ictal fear 11
Translating genes into health. 11
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. 11
New molecular approaches to Alzheimer's disease 11
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe 10
Integration of multigene panels for the diagnosis of hereditary retinal disorders using Next Generation Sequencing and bioinformatics approaches 10
Genetic testing in neurology exploiting next generation sequencing: State of art 10
Next Generation Sequencing: From Research Area to Clinical Practice 10
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype 9
Introduction to ion channels 8
Human neuronal nicotinic receptors and epilepsy during sleep 8
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 8
Personalized laboratory medicine: A patient-centered future approach 7
Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease 7
Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey 7
Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old 5
null 4
Value-Based Health Care Implementation: The Case Study of mTBI Biomarkers 3
Exploiting the Whole Exome Sequencing for the identification of new candidate genes associated with Brugada Syndrome 2
Totale 1.311
Categoria #
all - tutte 18.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 2 0 0 0 2 0 0
2020/202115 4 1 0 5 1 2 0 0 1 0 0 1
2021/202282 0 0 0 16 8 8 33 1 3 4 1 8
2022/2023434 133 85 37 0 14 57 13 29 16 2 25 23
2023/2024474 28 18 58 75 27 99 17 42 1 13 18 78
2024/2025269 126 17 30 51 45 0 0 0 0 0 0 0
Totale 1.311